Back
Unitil Vs. Kymera Therapeutics Industry Stock Comparison
Sell
34
UTL
Unitil
Last Price:
$52.24
Seasonality Move:
1.07%
Buy
70
KYMR
Kymera Therapeutics
Last Price:
$44.81
Seasonality Move:
20.91%
Sell
34
Unitil (UTL)
is a Sell
Is Unitil a Buy, Sell or Hold?
-
UTL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $44.79. The Score for KYMR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $44.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
UTL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 46.01 | Sell |
Chaikin Money Flow: | 16897 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.97 - 53.79) | Sell |
Bollinger Bands (100): | (53.4 - 57.7) | Sell |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.92 | Buy |
Relative Strength Index (14 RSI): | 58.43 | Buy |
Chaikin Money Flow: | 47554 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.09 - 49.29) | Buy |
Bollinger Bands (100): | (27.22 - 41.78) | Buy |
UTL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.28 | Buy |
20-day SMA: | 52.54 | Sell |
50-day SMA: | 54.65 | Sell |
200-day SMA: | 56.41 | Sell |
8-day EMA: | 52.37 | Buy |
20-day EMA: | 52.74 | Sell |
50-day EMA: | 53.96 | Sell |
200-day EMA: | 55.3 | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.11 | Sell |
20-day SMA: | 46.32 | Sell |
50-day SMA: | 38 | Buy |
200-day SMA: | 39.54 | Buy |
8-day EMA: | 44.94 | Sell |
20-day EMA: | 44.02 | Buy |
50-day EMA: | 39.8 | Buy |
200-day EMA: | 37.62 | Buy |
Unitil Earnings Growth & UTL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.32 per share, an increase this year of $0.17 per share, and an increase next year of $0.22 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.17 per share, a decrease this year of $0.67 per share, and a decrease next year of $0.49 per share.
Unitil Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |